WWU will lead WP4 (Inflammatory mechanisms: immune cell binding and transmigration in SVDs) and will contribute to WP2 (Blood brain barrier integrity and perivascular flow), WP3 (Microvascular matrisome and vascular integrity) and WP5 (Validation of mechanisms through interventions).
Prof. Lydia Sorokin
Full Professor and Director of Physiological Chemistry and Pathobiochemisty (C4), Münster University, Münster, Germany;Spokesperson of the Cells-in-Motion Cluster of Excellence, University of Münster;Member of the North Rhein-Westphalian Academy of Sciences, Humanities & Arts;External Advisory Board member of the University of Cologne, Center for Molecular Medicine (ZMMK);Scientific Steering Committee member of CRC Transregio 128 - Multiple Sclerosis;SmArt & SmArtER (Small Artery Re-modelling) Marie Curie Initial Training Network Steering Committees member
Prof. Sorokin is a work package leader (WP4) in SVDs@target.
Dr. Tushar Deshpande is a non-clinical pharmacologist by training with a broad interest in various neuropathologies and therapeutic strategies thereof. He is investigating the role of inflammation and innate immune system in the pathophysiology of cerebral small vessel diseases.
Dr. Jula Huppert
Postdoctoral scientistImmunologist with experience in ischemic stroke models and confocal microscopy of brain slices.